Relonchem receives UK MHRA marketing authorization for Exemestane 25mg film-coated tablets
05-Nov-25 11:13
Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its product Exemestane 25mg film-coated tablets from UK MHRA.